Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

‘Unprecedented’ breast cancer trial results explained

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

There’s a real sense of optimism around new ways of tackling lung cancer

From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.

Opening a window of opportunity for head and neck cancer

We take a look at our latest immunotherapy clinical trial, testing a new drug for people with head and neck cancers.

Cancer Research UK launches trial for potential new drug that could help immune system fight cancer

Cancer Research UK has launched a new clinical trial to test a drug that could stop a patient’s immune system from protecting tumours.

Immunotherapy cancer ‘cure’ headlines distract from fascinating science

We explore today's headlines about new US research on immunotherapy for blood cancers.

International Childhood Cancer Day: why an EU law needs improving to help develop new treatments for young people

We explore how an EU law potentially holding back progress in research on cancers that affect children and young adults.

New test could help select the best treatment for bowel cancer patients

A new test could help patients with advanced bowel cancer get the best treatment for their disease.

World Cancer Day 2016: six ways our research helps patients across the globe

To mark World Cancer Day, we take a look at how our discoveries over the decades are helping cancer patients all over the world right now.

Good progress in clinical trials transparency, but we need to do more

Stephanie Mathisen, Sense About Science Campaigns and Policy Officer, reflects on the successes of the AllTrials campaign over the past three years and the challenges that...